Clinical diagnostic criteria for dementia associated with Parkinson's disease

Movement Disorders - Tập 22 Số 12 - Trang 1689-1707 - 2007
Murat Emre1, Dag Aarsland2,3, Richard G. Brown4, David J. Burn5, Charles Duyckaerts6, Y Mizuno7,8, G. Anthony Broe9,10, Jeffrey L. Cummings11, Dennis W. Dickson12, Serge Gauthier13, Jennifer G. Goldman14, Christopher G. Goetz14, Amos D. Korczyn15, Andrew J. Lees16, Richard Lévy17, Irene Litvan18, Ian G. McKeith19, Warren Olanow20, Werner Poewe21, Niall Quinn22, Carla Sampaio23, Eduardo Tolosa24, Un Jung Kang25
1Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Ístanbul Faculty of Medicine, Ístanbul University, Ístanbul, Turkey
2Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway
3School of Medicine, University of Bergen, Norway
4King's College, MRC Centre for Neurodegeneration Research, Institute of Psychiatry, London, United Kingdom
5Institute for Ageing and Health, Newcastle University, Wolfson Research Centre, Newcastle upon Tyne, United Kingdom
6Neuropathology Laboratory, La Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679, Paris, France
7Department of Neurology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan
8Research Institute for Diseases of Old Ages, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan
9Ageing Research Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia
10Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales, Randwick, New South Wales, Australia
11Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
12Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA
13Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging, Montreal, Quebec, Canada
14Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
15Department of Neurology, Tel-Aviv University, Ramat -Aviv, Israel
16Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom
17Federation de Neurologie, INSERM U.610, AP-HP, Groupe Hospitalier Pitié-Salpetriere, Paris, France
18Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky, USA
19Wolfson Research Centre, Newcastle General Hospital, Newcastle upon Tyne, United Kingdom
20Department of Neurology and Department of Neuroscience, Mount Sinai School of Medicine, New York, USA
21Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria
22Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom
23Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Instituto de Medicina Molecular, Lisboa, Portugal
24Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Spain
25INSERM U610, Pavillon Claude Bernard, Hôpital de la Salpêtrière, Paris, France

Tóm tắt

Abstract

Dementia has been increasingly more recognized to be a common feature in patients with Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of dementia associated with PD (PD‐D), however, have been lacking. A Task Force, organized by the Movement Disorder Study, was charged with the development of clinical diagnostic criteria for PD‐D. The Task Force members were assigned to sub‐committees and performed a systematic review of the literature, based on pre‐defined selection criteria, in order to identify the epidemiological, clinical, auxillary, and pathological features of PD‐D. Clinical diagnostic criteria were then developed based on these findings and group consensus. The incidence of dementia in PD is increased up to six times, point‐prevelance is close to 30%, older age and akinetic‐rigid form are associated with higher risk. PD‐D is characterized by impairment in attention, memory, executive and visuo‐spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent. There are no specific ancillary investigations for the diagnosis; the main pathological correlate is Lewy body‐type degeneration in cerebral cortex and limbic structures. Based on the characteristic features associated with this condition, clinical diagnostic criteria for probable and possible PD‐D are proposed. © 2007 Movement Disorder Society

Từ khóa


Tài liệu tham khảo

McKeith IG, 2000, Neurologic clinics, 865

10.1212/01.wnl.0000187889.17253.b1

10.1212/01.WNL.0000036610.36834.E0

10.1177/089198878800100106

10.1002/mds.20527

10.1002/mds.20216

10.1093/ageing/afi098

10.1001/archneur.62.8.1265

10.1016/S0967-5868(96)90028-4

10.1093/brain/awh067

10.1002/mds.20513

10.1212/WNL.56.6.730

10.1002/mds.20489

10.1001/archneur.1995.00540310069018

10.1093/ageing/afj030

10.1002/mds.20324

Portin R, 1986, Predictive factors for cognitive deterioration and dementia in Parkinson's disease, Adv Neurol, 45, 413

10.1001/archneur.60.3.387

10.1212/WNL.54.8.1596

Aarsland D, The effect of age of onset of PD on risk of dementia, J Neurol

10.1212/01.wnl.0000249130.63615.cc

10.1002/mds.870130605

10.1002/ana.10219

10.1136/jnnp.51.12.1498

McFadden L, 1996, A profile analysis of demented and nondemented Parkinson's disease patients, Adv Neurol, 69, 339

10.1001/archneur.61.12.1906

10.1136/jnnp.2005.081711

10.1016/0028-3932(89)90167-X

10.1093/brain/114.5.2095

10.1016/0028-3932(93)90149-T

Levin BE, 1995, Behavioral neurology of movement disorders, 85

10.1136/jnnp.2003.033530

10.1037/0894-4105.9.1.126

10.1177/0891988705277540

10.1136/jnnp.64.2.178

10.1136/jnnp.74.9.1215

Cahn‐Weiner DA, 2002, Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease, Neuropsychiatry Neuropsychol Behav Neurol, 15, 79

10.1136/jnnp.54.1.25

10.1177/089198879500800308

10.1002/mds.10633

Beatty WW, 2003, Analyzing the subcortical dementia syndrome of Parkinson's disease using the RBANS, Arch Clin Neuropsychol, 18, 509

10.1212/01.WNL.0000036908.39696.FD

10.1136/jnnp.61.4.381

10.1001/archneur.1993.00540040036010

Kuzis G, 1999, Explicit and implicit learning in patients with Alzheimer disease and Parkinson disease with dementia, Neuropsychiatry Neuropsychol Behav Neurol, 12, 265

10.1037/1040-3590.6.2.129

10.1016/0028-3932(89)90036-5

10.1080/13803390490515469

10.1037/0894-4105.14.2.233

10.1080/01688639608408310

10.1056/NEJMoa041470

10.1097/00146965-200306000-00001

10.1002/gps.1094

10.1212/01.WNL.0000145764.70698.4E

10.1212/WNL.38.5.680

10.1002/mds.20726

10.1136/jnnp.2003.033530

10.1212/WNL.44.12.2308

10.1111/j.1600-0447.2005.00562.x

10.1136/jnnp.67.4.492

10.1176/jnp.13.1.42

10.1093/brain/123.4.733

10.1002/gps.389

10.1002/1099-1166(200102)16:2<184::AID-GPS304>3.0.CO;2-K

10.1136/jnnp.2005.083113

10.1111/j.1532-5415.2000.tb06891.x

Hirono N, 1999, Distinctive neurobehavioral features among neurodegenerative dementias, J Neuropsychiatry Clin Neurosci, 11, 498

10.1176/ajp.156.7.1039

10.1002/1099-1166(200102)16:2<184::AID-GPS304>3.0.CO;2-K

Benoit M, 2005, One‐year longitudinal evaluation of neuropsychiatric symptoms in Alzheimer's disease. The REAL.FR Study, J Nutr Health Aging, 9, 95

10.1136/jnnp.62.1.16

10.1016/S1474-4422(05)70146-0

10.1097/01.JGP.0000192480.89813.80

Hirono N, 1998, Neuropsychiatric features in dementia with lewy bodies and Alzheimer's disease, Brain Nerve, 50, 45

10.1016/0006-3223(93)90237-8

10.1002/gps.1395

10.1002/1099-1166(200011)15:11<1034::AID-GPS231>3.0.CO;2-5

10.1007/BF01249089

10.3109/00207458909002162

10.1212/WNL.55.4.539

10.1212/WNL.35.4.522

10.1002/mds.10455

10.1002/mds.20897

10.1002/1531-8257(199901)14:1<10::AID-MDS1005>3.0.CO;2-4

10.1111/j.1600-0404.1995.tb00480.x

10.1001/archneur.56.3.334

10.1097/00002826-198908000-00006

10.1136/jnnp.72.6.721

10.1002/mds.20347

10.1111/j.1532-5415.2005.53552.x

10.1136/jnnp.2005.074070

10.1093/brain/112.5.1193

10.1093/brain/awh484

10.1002/mds.20719

10.1002/mds.20582

10.1093/brain/123.2.331

10.1212/WNL.58.10.1544

10.1212/WNL.51.6.1760

Kenny RA, 2006, Dementia with Lewy bodies and Parkinson's disease dementia, 107

10.1212/WNL.37.9.1539

10.1212/WNL.40.8.1222

10.1007/s007020050005

10.1212/WNL.43.9.1690

10.1111/j.1468-1331.2004.00826.x

10.1007/s00115-001-1234-7

10.1212/01.WNL.0000130194.84594.96

Molloy S, The motor response to levodopa in dementia with Lewy bodies: a comparison to Parkinson's disease with and without dementia, J Neurol Neurosurg Psychiatry

10.1136/jnnp.58.1.51

10.1016/S0006-8993(02)03396-6

Goetz CG, 2002, Management of Parkinson's disease: an evidence‐based review, Mov Disord, 17, 120

10.1002/mds.1204

10.4088/JCP.v66n0514

10.1159/000070676

10.1093/brain/awh088

10.1002/mds.20652

10.1002/mds.10444

10.1002/mds.20371

10.1001/archneur.62.2.281

10.1212/01.WNL.0000153070.82309.D4

10.1002/mds.20704

10.1007/s100720170039

10.1016/S1053-8119(03)00364-1

10.1159/000084551

10.1177/089198879100400404

10.1097/00006231-199213100-00007

10.1016/j.clineuro.2004.12.005

10.1002/mds.20463

10.1136/jnnp.55.10.960

10.1136/jnnp.54.9.787

10.1007/BF00593259

10.1002/gps.1359

10.1002/jnr.490270417

Piert M, 1996, Determination of regional rate constants from dynamic FDG‐PET studies in Parkinson's disease, J Nucl Med, 37, 1115

Vander Borght T, 1997, Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity, J Nucl Med, 38, 797

10.1212/01.wnl.0000191154.78131.f6

10.1007/s00415-005-0971-0

10.1093/brain/awf134

10.1001/archneur.57.4.470

10.1007/s00259-005-1830-z

10.1001/archneur.61.6.919

Bowen BC, 1995, Proton MR spectroscopy of the brain in 14 patients with Parkinson disease, Am J Neuroradiol, 16, 61

10.1001/archneur.59.9.1415

10.1016/S0022-510X(97)00278-5

Satoh A, 1999, Loss of 123I‐MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value, J Nucl Med, 40, 371

10.1136/jnnp.67.2.189

Takatsu H, 2000, Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG, J Nucl Med, 41, 71

10.1007/s002590050544

10.1136/jnnp.71.5.583

10.1007/s00401-005-0995-7

10.1212/WNL.53.5.1020

10.1016/S0022-510X(00)00279-3

10.1007/s002590050548

10.1016/0013-4694(91)90134-P

Neufeld MY, 1994, EEG frequency analysis in demented and nondemented parkinsonian patients, Dementia, 5, 23

Sinanovic O, 2005, EEG frequency and cognitive dysfunction in patients with Parkinson's disease, Med Arh, 59, 286

Hayashi R, 1993, Event‐related potentials, reaction time, and cognitive state in patients with Parkinson's disease, Adv Neurol, 60, 429

10.1177/089198879300600301

10.1016/0022-510X(94)90342-5

Aotsuka A, 1996, Event‐related potentials in Parkinson's disease, Electromyogr Clin Neurophysiol, 36, 215

10.1016/S0022-510X(97)05372-0

10.1016/S0022-510X(98)00102-6

10.1136/jnnp.67.4.497

10.1002/ana.1221

10.1016/S0022-510X(01)00674-8

10.1136/jnnp.2003.035022

10.1212/WNL.54.6.1272

10.1006/geno.2002.6707

10.1002/mds.20481

10.1097/00002093-199803000-00007

10.1002/ana.410370215

10.1212/WNL.44.7.1330

10.1126/science.276.5321.2045

10.1126/science.1090278

10.1002/ana.10795

10.1016/S1353-8020(97)00013-8

10.1002/ana.410400513

10.1212/WNL.52.4.719

10.1046/j.1468-1331.2003.00532.x

10.1001/archneur.61.7.1033